3'-脱氧腺素通过抑制NLRP3炎症酶组来缓解甲基胺诱导的异常突触可塑性和寻求行为
Yize Qi1, Yao Zhou1, Jiyang Li1
1Institute for Stem Cell and Neural Regeneration and Key Laboratory of Cardiovascular & Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Neural regeneration research
|March 15, 2024
概括
源自Cordyceps militaris的3'-deoxyadenosine通过抑制NLRP3炎症体,恢复突触可塑性和预防神经元损伤来减少甲基成行为.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 甲胺成包括持续寻找药物的行为和异常的突触可塑性.
- 含有-3 (NLRP3) 炎症酶的NOD类受体家族皮林域与异常的突触可塑性有关.
- 来自Cordyceps militaris的3'-脱氧腺素表现出抗炎性质.
研究的目的:
- 通过NLRP3炎症酶抑制,研究3'-脱氧亚地诺辛是否可以减弱甲基胺诱导的异常突触可塑性.
- 探索3'-脱氧腺在甲基胺成中的治疗潜力.
主要方法:
- 向甲基胺治疗的小鼠注射3'-脱氧氨酸.
- 评估了条件化的位置偏好,c-fos表达,谷氨酸转移和突触可塑性.
- 测量NLRP3表达,神经元损伤,并使用NLRP3淘汰赛小鼠.
主要成果:
- 3′-脱氧腺减少了甲基胺诱导的寻找行为和c-fos表达.
- 它恢复了突触可塑性和谷氨基质传递,同时降低了NLRP3表达和神经元损伤.
- NLRP3缺陷模仿了这些保护作用,而NLRP3激活则逆转了它们.
结论:
- 3'-脱氧腺因抑制NLRP3炎症体而减轻甲基胺诱导的异常突触可塑性和寻求行为.
- 这表明,针对神经炎症的甲基胺成是一种潜在的治疗策略.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
192
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
192
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena
469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469


